US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy device.
The US Food and...
NovoCure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression of brain metastasis in...
Digital healthcare company Cleerly has announced that positive data from two studies investigating its AI-QCT ISCHEMIA software device has been published.
Cleerly’s ISCHEMIA software device...
Nyxoah’s hypoglossal nerve stimulation system, Genio, met the co-primary endpoints at 12 months in the pivotal DREAM trial in adults with obstructive sleep apnoea...
Spineart has successfully completed patient enrollment in its pivotal US investigational device exemption (IDE) trial for the BAGUERA C cervical disc prosthesis.
The BAGUERA C...
The Cleveland-based augmented reality (AR) firm, MediView XR, has announced the results of a trial studying its XR90 surgical visualization and navigation system, finding...
Paris-based device company Carthera has announced that its SonoCloud-9 system can help certain drugs pass the brain-blood barrier, as part of positive results from...
Nano-X Imaging (Nanox) has announced a collaboration with Israeli Beilinson Hospital to conduct a clinical study assessing the diagnostic capabilities of the Nanox.ARC 3D...
Aria CV has kicked off its ASPIRE PH trial and successfully implanted the first patient with its system to treat pulmonary hypertension.
The patient was...
